An experimental new CAR-T therapy shows high efficacy in multiple myeloma, even against treatment resistance
A study led by the Clínic Barcelona Comprehensive Cancer Center —a center driven by Clínic-IDIBAPS and the University of Barcelona (UB)— demonstrates1